Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | LTA4H | P09960 | 2/20 | 0.41 |
| ▸ | RECQL | P46063 | 1/20 | 0.38 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | RARB | P10826 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10232106 | 0.84 | LTA4H (0.42) | TSHRALDH1A1HPGDLTA4HRECQL | |
| SCHEMBL12409056 | 0.81 | ALDH1A1 (0.42) | TSHRALDH1A1LTA4H | |
| SCHEMBL2009823 | 0.80 | HDAC1 (0.36) | TSHRALDH1A1MEN1KMT2A | |
| SCHEMBL16933755 | 0.80 | ALDH1A1 (0.41) | TSHRALDH1A1LTA4HMEN1KMT2A | |
| Trifluoromethylbenzene SCHEMBL9651235 | 0.79 | ALDH1A1 (0.52) | TSHRALDH1A1HPGDLTA4HPTGDR2 | |
| SCHEMBL2323605 | 0.78 | SIGMAR1 (0.40) | TSHRALDH1A1MEN1KMT2A | |
| SCHEMBL16933716 | 0.78 | SIGMAR1 (0.40) | TSHRALDH1A1MEN1KMT2A | |
| SCHEMBL20636787 | 0.78 | SIGMAR1 (0.40) | TSHRALDH1A1MEN1KMT2A | |
| SCHEMBL16367918 | 0.78 | CES1 (0.49) | TSHRALDH1A1LTA4HHRH3 | |
| SCHEMBL1722311 | 0.78 | CES1 (0.49) | TSHRALDH1A1LTA4HHRH3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3925945-A1 | METHOD FOR PRODUCING FLUORINATED COMPOUND | Daikin Industries, Ltd. (JP) | 2021-12-22 | — | — | EP | disclosed |
| EP-3428145-B1 | METHOD FOR PRODUCING FLUORINATED COMPOUND | DAIKIN IND LTD (JP) | 2021-09-08 | — | — | EP | disclosed |
| US-20190071376-A1 | METHOD FOR PRODUCING FLUORINATED COMPOUND | DAIKIN INDUSTRIES, LTD. (JP) | 2019-03-07 | — | — | US | disclosed |
| EP-3428145-A1 | METHOD FOR PRODUCING FLUORINATED COMPOUND | Daikin Industries, Ltd. (JP) | 2019-01-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190071376-A1 | METHOD FOR PRODUCING FLUORINATED COMPOUND | RXFP2, BLVRB, AFF2 | TSHR 172/4885ALDH1A1 1416/4885HPGD 990/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.